|
|
.
See Category: Factors influencing health status and contact with health services
ICD-10 (CM) Code and Descriptor
|
Z12.2 |
Encounter for screening for malignant neoplasm of respiratory organs
This code is considered unacceptable as a principal diagnosis.
|
Z122 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 63.16%
|
15.81%
|
5.67%
|
3.69%
|
2.63%
|
2.13%
|
1.79%
|
1.41%
|
1.06%
|
0.79%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for Z12.2*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
71271
|
CT THORAX LUNG CANCER SCR C- |
119,267
|
119,268
|
|
G1004
|
CDSM NDSC |
10,893
|
10,968
|
|
71250
|
CT THORAX DX C- |
6,354
|
6,354
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
2,962
|
2,972
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
2,763
|
2,766
|
|
76706
|
US ABDL AORTA SCREEN AAA |
1,851
|
1,851
|
|
80053
|
COMPREHEN METABOLIC PANEL |
1,706
|
1,706
|
|
77080
|
DXA BONE DENSITY AXIAL |
1,600
|
1,600
|
|
77067
|
SCR MAMMO BI INCL CAD |
1,501
|
1,501
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
1,406
|
1,407
|
|
80061
|
LIPID PANEL |
1,404
|
1,404
|
|
94729
|
CO/MEMBANE DIFFUSE CAPACITY |
1,336
|
1,336
|
|
94060
|
EVALUATION OF WHEEZING |
1,182
|
1,182
|
|
77063
|
BREAST TOMOSYNTHESIS BI |
1,178
|
1,178
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
1,096
|
97,025
|
|
94726
|
PULM FUNCT TST PLETHYSMOGRAP |
1,025
|
1,025
|
|
84443
|
ASSAY THYROID STIM HORMONE |
885
|
886
|
|
83036
|
HEMOGLOBIN GLYCOSYLATED A1C |
794
|
794
|
|
76376
|
3D RENDER W/INTRP POSTPROCES |
794
|
796
|
|
71046
|
X-RAY EXAM CHEST 2 VIEWS |
681
|
682
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
Z12.2 related to the following DRG Codes:
951
|
